Page last updated: 2024-08-26

lysophosphatidic acid and pitavastatin

lysophosphatidic acid has been researched along with pitavastatin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujimura, T; Hayashida, A; Kaneyuki, U; Kato, S; Kojiro, M; Okuda, S; Oshima, K; Shibata, R; Ueda, S; Yamagishi, S; Yoshimura, J	1

Other Studies

1 other study(ies) available for lysophosphatidic acid and pitavastatin

Article	Year
Pitavastatin inhibits lysophosphatidic acid-induced proliferation and monocyte chemoattractant protein-1 expression in aortic smooth muscle cells by suppressing Rac-1-mediated reactive oxygen species generation. Vascular pharmacology, 2007, Volume: 46, Issue:4 Topics: Antioxidants; Aorta; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Dose-Response Relationship, Drug; Gene Expression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lysophospholipids; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Quinolines; rac1 GTP-Binding Protein; Reactive Oxygen Species; Receptors, Lysophosphatidic Acid; RNA, Messenger; Signal Transduction; Transfection	2007

Article

Year

Pitavastatin inhibits lysophosphatidic acid-induced proliferation and monocyte chemoattractant protein-1 expression in aortic smooth muscle cells by suppressing Rac-1-mediated reactive oxygen species generation.

Vascular pharmacology, 2007, Volume: 46, Issue:4

Topics: Antioxidants; Aorta; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Dose-Response Relationship, Drug; Gene Expression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lysophospholipids; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Quinolines; rac1 GTP-Binding Protein; Reactive Oxygen Species; Receptors, Lysophosphatidic Acid; RNA, Messenger; Signal Transduction; Transfection

2007